COMPARE · Reviewed August 3, 2026
BTSG vs WAY
Verdict: Side-by-side breakdown using the Bull Rankings model. BTSG scored 56.8, WAY scored 58.9 — WAY leads.
Compare another set
BTSG
BrightSpring Health Services, Inc.
56.8
$63.13 · $12.5B
fundamentals as of
Score gap
2.1
WAY leads
WAY
Waystar Holding Corp.
58.9
$23.40 · $4.5B
fundamentals as of
The model, pillar by pillar (0–100 each)
BTSG
stronger →← stronger
WAY
51
Qualityreturns · margins · balance sheet
47
100
Growthrevenue & earnings expansion
95
36
Valuevaluation vs sector peers
45
BTSG is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
BTSG
WAY
$402mC
FCF
$246mC
+26.4%A-
Rev
+19.2%B+
1.16C
D/E
0.37B
56.4xC
P/E
33.4xC+
1.92C+
PEG
1.96C+
Winner per row is the stronger grade in our model; a tie or a missing value shows no highlight.
Valuation · DCF cross-check
BTSG
WAY
129% above
Price vs fair valuelower is cheaper
0% above
~39%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
-66%
1-yr DCF upside
-12%
-56%
5-yr DCF upside
0%
-38%
10-yr DCF upside
+19%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
BTSG
Why this score
- Diluting shareholders
- Short track record
WAY
Why this score
- Diluting shareholders
- Short track record
The companies
BTSGBrightSpring Health Services, Inc.
Why now
Health Information Services · market cap $12.5b. 14% off the 52-week high of $73.75. Revenue growing +26% — in hypergrowth territory. 17 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $78.53 (implying +24% upside).
Moat
ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 110% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Trailing P/E 56.4x prices in sustained high growth — any quarter that disappoints triggers sharp re-rating. Beta 1.88 implies above-market volatility — position-size to the drawdowns this name will produce in a market correction, not to its bull-case return. Net margin 2.5% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
WAYWaystar Holding Corp.
Why now
Health Information Services · market cap $4.5b. Down 44% from 52-week high of $41.47 — deep drawdown territory. Revenue growing +19%, comfortably above the S&P median. 23 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $33.22 (implying +42% upside).
Moat
FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 44% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 33x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates. ROE 3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.